Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
02/2002
02/06/2002EP0882024B1 Retroviral protease inhibiting compounds
02/06/2002EP0863882B1 Amino substituted pyrimidines and triazines
02/06/2002CN1334816A Triazolo (4,5-D) pyrimidine compounds
02/06/2002CN1334806A Beta-amide and beta-sulfonamide carboxylic acid derivs., their preparation and their use as endothelin receptor antagonists
02/05/2002US6344559 Quinazoline derivative, silylating agent and a chloroalkyl carboxy compound, then desilylation
02/05/2002US6344485 Method for treating glaucoma
02/05/2002US6344459 Treating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis
02/05/2002US6344455 Treating cancer, atherosclerosis, restenosis, endometriosis, and psoriasis
02/05/2002US6344447 Administering mixture of nucleosides; anticancer agent
02/05/2002US6344213 Compounds and compositions for delivering active agents
01/2002
01/31/2002WO2002008475A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
01/31/2002WO2002008207A1 Process for the preparation of 4,6-dimethoxy-2-(methylsulfonyl)-1,3-pyrimidine
01/31/2002WO2002008206A1 3-amino-2-(4-aminocarbonyloxy)phenyl-propionic acid derivatives as alpha-4- integrin inhibitors
01/31/2002WO2002008205A1 Substituted 5-alkynyl pyrimidines having neurotrophic activity
01/31/2002WO2002008204A2 5-substituted pyrimidine derivatives of conformationally locked nucleoside analogues
01/31/2002WO2002008203A2 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by vla-4
01/31/2002WO2002008202A2 Alpha amino acid derivatives--inhibitors of leukocyte adhesion mediated by vla-4
01/31/2002WO2002008201A2 Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by vla-4
01/31/2002WO2002008200A2 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists
01/31/2002WO2002008191A1 Potassium channel inhibitors
01/31/2002WO2002008176A1 Substituted sulfonyl aminomethyl benzoic acid (derivatives) and method for the production thereof
01/31/2002WO2002007729A1 Non-sedating barbiturate compounds as neuroprotective agents
01/31/2002WO2001070737A3 Therapeutic heterocyclic compounds for the treatment of asthma and allergy and use thereof
01/31/2002WO2001021160A3 Carboxymide and aniline derivatives as selective inhibitors of pathogens
01/31/2002US20020013497 Alkylation, blocking
01/31/2002US20020013466 Herbicides
01/31/2002US20020013330 Providing sedative-hypnotic treatment by administering barbiturate derivative compound
01/31/2002US20020013329 For therapy of pain, migraine, depression, anxiety, schizophrenia, Parkinson's disease, stroke, and in therapy of neuropathies including postherpetic neuralgia, central pain from spinal cord injury, and phantom limb pain
01/31/2002US20020013317 For therapy and prophylaxis of psychotic disorders such as schizophrenia and other central nervous system disease
01/31/2002US20020013316 Nitrogen-containing heterocyclic carboxamide derivatives or salts thereof and antiviral agents comprising the same
01/31/2002US20020013299 For enhancing the chemotherapeutic treatment of tumor cells in a mammal with an antineoplastic alkylating agent, which causes cytotoxic lesions at the O6-position of guanine; O6-alkylguanine-DNA alkyltransferase (AGT) inactivator
01/31/2002US20020012977 Enzymatic oxidations
01/31/2002US20020011588 Liquid crystalline compounds
01/31/2002DE10034803A1 Substituierte Sulfonsäureanilide Substituted Sulfonsäureanilide
01/31/2002DE10034801A1 Substituierte Amidoalkyl-uracile und ihre Verwendung Substituted amidoalkyl uracils and their use
01/31/2002CA2416870A1 Potassium channel inhibitors
01/30/2002EP1176184A2 Mesomorphic compound, polymeric mesomorphic compound, and electrolyte and secondary battery including same
01/30/2002EP1175409A1 Pyrimidinones derivatives for the treatment of atherosclerosis
01/30/2002EP1175408A1 Pyrimidinone compounds
01/30/2002EP1175407A1 Pesticidal pyrimidine-derivatives
01/30/2002EP1175404A1 Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
01/30/2002EP1175383A1 Glucocorticoid receptor modulators
01/30/2002EP0907634B1 Pesticides
01/30/2002EP0866791B1 Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial
01/30/2002EP0836602B1 Fungicidal pyrimidinones
01/30/2002CN1333768A Pyrimidinylbenzimidazole and triazinylbenzimidazole derivatives and agricultural/horticultural bactericides
01/30/2002CN1333758A Substituted bicyclic derivatives useful as anticancer agents
01/30/2002CN1333757A Quinazoline derivatives as medicaments
01/30/2002CN1333756A Crystalline bis [(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl (methylsulfonyl)amino] pyrimidin-5-yl](3R,5S-3,5-dihydroxyhept-6-enoic acid] calcium salt
01/29/2002US6342633 O-benzyl oxime ether derivatives and their use as pesticides
01/29/2002US6342608 Reacting organometallic reagent with activated carboxylic acid to form ketone, treating with mixture of carbon disulfide and dihalomethane to form dithietane, reacting with hydrazine derivative to form thiol-substituted pyrazole, alkylating
01/29/2002US6342604 Treating schizophrenia, depression, neuroses and psychoses which respond to dopamine d3 ligands
01/29/2002US6342534 Analogs of biologically active, naturally occurring polyamines, pharmaceutical compositions and methods of treatment
01/29/2002US6342508 N-hydroxy-2-(Alkyl,Aryl or Heteroaryl sulfanyl, sulfinyl or sulfonyl) 3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
01/29/2002US6342504 Peptides as antithrombins and anticoagulants
01/29/2002US6342503 Antidepressants, eating disorders
01/29/2002US6342502 Thieno[2,3-d]pyrimidine diones and their use in the treatment of reversible obstructive airways diseases
01/29/2002US6342379 Detection of transmembrane potentials by optical methods
01/29/2002US6342244 Hydrophilic polymer covalently yet reversibly linked to a amine-containing ligand through a dithiobenzyl linkage; modification of various substrates, such as polypeptides, drugs and liposomes; upon cleavage of the linkage, the ligand
01/29/2002CA2048347C Process for the preparation of deoxynucleosides
01/24/2002WO2002006259A1 Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides (iv)
01/24/2002WO2002006247A1 Substituted amidoalkyl-uracils as parp inhibitors
01/24/2002WO2002006246A1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors
01/24/2002WO2002006245A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof
01/24/2002WO2002006244A1 Heterocyclic substituted herbicidal sulphonic acid anilides
01/24/2002WO2002006243A1 Tetrahydropyrimidines as pesticides
01/24/2002WO2002006242A2 5-substituted 2-aryl-4-pyrimidinones
01/24/2002WO2002006189A2 Aniline derivatives
01/24/2002WO2001052892A3 Jak/stat pathway inhibitors and the uses thereof
01/24/2002WO2001027107A3 Heterocyclic sodium/proton exchange inhibitors and method
01/24/2002US20020010338 Phenyl-keto-imidazolidine thioamide derivatives
01/24/2002US20020010334 Alkylation, amination, haloalkylation, nitriding pyrimidinedione in presence of a base
01/24/2002US20020010186 Dihydropyrimidines and uses thereof
01/24/2002US20020010185 Anticarcinogenic agents
01/24/2002US20020010173 Reacting an amide derivative with a piperidine containing guanidine group to produce the product
01/24/2002US20020009650 High electroconductivity
01/24/2002DE19963234A1 New N,N-disubstituted piperazine and diazacycloheptane derivatives useful in treatment of hyperlipidemia, atherosclerosis, diabetes mellitus, adiposity and pancreatitis
01/24/2002DE10034130A1 Heterocyclische Fluoralkenylthioether (lV) Heterocyclic fluoroalkenyl thioethers (IV)
01/24/2002CA2418288A1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors
01/24/2002CA2416248A1 5-substituted 2-aryl-4-pyrimidinones
01/24/2002CA2416036A1 Substituted amidoalkyl-uracils as parp inhibitors
01/24/2002CA2384041A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof
01/23/2002EP1174461A1 Thermally stabilized PVC compositions
01/23/2002EP1174151A1 Preventive or therapeutic drugs for various eosinophilia-related diseases containing chymase inhibitors as the active ingredient
01/23/2002EP1173424A1 Pyrimidine compounds
01/23/2002EP1173222A2 Conjugate having a cleavable linkage for use in a liposome
01/23/2002EP1173206A1 Contraceptive compositions containing quinazolinone and benzoxazine derivatives
01/23/2002CN1332747A 2'-fluoronucleosides
01/23/2002CN1332168A 3-substituted pyrido-[4',3':4,5] thieno-[2,3-d] pyrimidine derivatives, their prep. and use
01/23/2002CN1332162A Technological process of producing orotic acid
01/23/2002CN1332161A Method for preparing sulfamine urea compound
01/23/2002CN1332160A Process for prep. of 4-hydroxy-phenyl butanone
01/23/2002CN1078204C Amino acid amide derivative and fungicidal use and production process thereof
01/22/2002US6340780 Method of preparing salts of dinitromethane
01/22/2002US6340757 6-(1-fluoroalkyl)-4-pyrimidones and processes for producing the same
01/22/2002US6340687 Substituted tetrahydro-pyrimidine-2(1H)-thione HDL-C elevators useful as antiatherosclerotic agents
01/22/2002US6340679 Guanidine derivatives as inhibitors of cell adhesion
01/22/2002CA2102457C Erythromycin derivatives, process for the preparation thereof, and use thereof as medicaments
01/22/2002CA2064872C Aryloxymethylcarbonochloridate ester intermediates, their production and use in synthesizing prodrugs and their use therefor
01/22/2002CA2037838C Herbicidal sulfonylureas, the preparation thereof and intermediates therefor